ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001063.1|Undecylprodigiosin_1 # 1 # 1053 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0001063.1|Undecylprodigiosin_1 	1	1053	+	Loose	400	28.8758	vanR gene in vanI cluster	26.76	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGACGGGTGGGGGAGTGCTTGCCACGATGGACCCGGTTCGAAAACTGGTCCGGAGCCAGCCAAAGATCGGGCGGCACCCCGTCGCGGCCGGTCAGGACGGCCGCGACCGGCACCCCATCCGCTCATGGGAGTGCGGAGAACGCGCGAGGACGGCCCGGACCGGCAGGACGGTCGGCCGCGCGGCCGACCCCTCGGACCACGGACCCAGCCTGTACAACTTCGGGGGATGCGTGGAAATCAACATATTGGGACCCGTATCGATCGACACGTCGCACAGCGGCGGCGGCATCCGGGCCGGCAAGGTCCGTACGCTGGTGGCGACGCTCGCCATCGACGCGGGCCGCGCCGTGTCGCTCGCGGACCTGGTGGACGAACTGTGGGGCGCGACCCCGCCCGACAACGTCCTCAACGCCCTCCAGGCGCATGCCGCTCGGGCCCGGAAAGTGCTCAACGAGCGTGCCTGCCCCGAGCGGGCGGGCGGCATCCTGCGTTCCGTGCTCGGCGGCTACCTGCTGGAGATCGACCCGCAGTGCGTGGACGGCAACCGCTTCCTGAGACTCGTCTCGCAGGGCGCCGCCCTGCTCCCCGCCGACCCCACGCGCGCCGTCGAACTGCTGGAGACCGGTCTGCGGCTGTGGCGCGGGCCCGCCCTCATCGACGCGGGTGAGGGCAGGCGCTGCCGGGGCGCCGCGGCCCTGTTCGAGGAACGCAGGCTCACGGCCCTGGAGGATCTCATCAGCGCGATGTTCCTGCGCGGCGGCGAGGCCCAGGCGATCGCCATGCTCCAGCAGCTGGTGGCGCAGTACCCACTGCGCGAGCGGTTCTGCGAGCTGCTGATGGTCGGCCTCTACCGGGTGGGACGTCAGGGAGACGCCCTGGAGTCGTACCGCCTGGCCAGGAAGCGGCTCGACGACGAACTGGGGGTCCAGCCGGGCGCGCTGCTGCGCCGACGGCACGCCGAGATCCTCGCGCAGGACCCGGTCCTCAAGGTGCCCTCCGCGCTGTGGCGCGAACCGTACGCGCCCGCCGACACCAGCCTGCTCAGCGCCTGA	MTGGGVLATMDPVRKLVRSQPKIGRHPVAAGQDGRDRHPIRSWECGERARTARTGRTVGRAADPSDHGPSLYNFGGCVEINILGPVSIDTSHSGGGIRAGKVRTLVATLAIDAGRAVSLADLVDELWGATPPDNVLNALQAHAARARKVLNERACPERAGGILRSVLGGYLLEIDPQCVDGNRFLRLVSQGAALLPADPTRAVELLETGLRLWRGPALIDAGEGRRCRGAAALFEERRLTALEDLISAMFLRGGEAQAIAMLQQLVAQYPLRERFCELLMVGLYRVGRQGDALESYRLARKRLDDELGVQPGALLRRRHAEILAQDPVLKVPSALWREPYAPADTSLLSA	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	150.86	gnl|BL_ORD_ID|2065|hsp_num:0	2246			489	693	vancomycin; teicoplanin
BGC0001063.1|Undecylprodigiosin_2 # 1238 # 4051 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.764	BGC0001063.1|Undecylprodigiosin_2 	1238	4051	+	Loose	300	30.0314	AAC(2')-IIa	40.0	3004628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	ATGTCCGCCCTCTATCCGGGAGCCCAAGGCGTCGAGGACCTGTGGCGGCTGCTGCTCGCCGACGGTCCGGCGCCCGCCTCCGGCACCGGGCCCGCGCCCGGCGGCCTCGGTGACATCGAGGTCGACGTGGCACGGTTCGGGATCCCGCCGGCCCAGGCCGCCTCCATGGCCCGCCTGCAACTGCTCATGGTGGAGGCGGCCCGCCAGTGCCTCGACGACGCCACCGGCTCCGGTGCCGACCGAGGGCGCACGGACGTCGTCGTGGGCACCTGCCTCGGCCTGGACCGGCAGTACGCCAACGCCCTGCGCGTCGACGGCGCCCGCTACGCCCGGGACCTGACGGAGGTCCTCGCGGACGGCGCCTGGCGCGACACCGGCATCGACGCGCGGGCCGCCGGGCAAGAACTCAACGACGCGCTGTCGCGCCGGCTGGGCGCCTCACCGCACGACCGGGTGGGCGAGATGGCCAGTACGATCCCGGCCCGCATCGCGTCGGCCTTCAAGCTGCGCGGGCGCACCCTCGCCGTCGAGTCGGCGGACGCCACCTCGTACCTGGCTCTCGCGCACGCCGTGGACAACCTGCGCGCGGGGCTCGCCGAGGCCGTCCTGGTCGTGGTGGGGCAGCGTGACGAGGGCCGTTTCGCGCGGCGGGCGCTGGCGGCCAAGGGGTTCGCCGCCCGACCCTCCGAGGCGGGCGCCGGGGACGCTCCCGTCCTCACGGAGGGGCTCGGGGCGCTGCTGCTCAAGCGCCGGTCGACCGCGGAGCGGGACGGCGACCGGGTGTACGCGTCGGTCCTGGACTGCGCCCTGCGGCACGAGGCGCGGCCGGGGATCTTCCGCTACTCGCTGTCGGCCGCGCACCGCCGGGCCGCCGCCGAGGCCGCGCACCGTACGGCGGACGTCGCGCCGGGATCCGTACGGCTCGTCGAGTGCGCCGGATACGGCACGGCCGCCGTGGGGCGCGCCGAACAGGAGGCGATCGCCGGGATCCACGCCGGTGCGCCCCGGGACTCGGTGGCCGTGGGCACCGTGCGCGACCGGCTCGGCCACACCTTCGCCAACGCCGGGCTCGCCGGTGTCACCAAGGCGGCGCTGGCCCTGCACCACCGCACCGTCCCCCCGGTGCTGCCCGGCACGGATCCCGCCCCGACGACCGGTCCGTTCCGCGTCCCGCGCGCGGCCGAGCCCTGGGAGCCGTCCACCGACGGCACGCCCCGGCGCGCCGCGGTCCTGGGCGCCTCACTGACCGGCACCGTATGCCACGTGCTCCTGGAGGAAGCCGCACCGGCCGGCTCCGTGCCCCAGGGGGCGGGCGCCGACGCACACCTCGGCGGTGCGCGCGCCGCCGGTGCGGCCCGGCGGCGGTTCCCGGGCGGGCAGGCGTCCGCCGCGGGCCGCGAGACCGGGGCGTGGCAGGCGGAGCCCATCGCGATCGTCGGGTTCGGTGGTCGTTTCGCCGACTCGCCCGACGCGGACGGGTTCTGGCGGACCATGCTCTCCGGGCGGGACCGGATCGGGCCGTTGCCGGCCGAGTTGTTCGACCGGGACCTCTACCACGCCCCCGGCGCACTCGCCCTCGGGCGCAGTTACACCGACCTGGGCGCGCCCGTCCCGGTGCCGACGCAGCCGCCCCCCGGGCTGCGCATCCCCCCGCACCGGTACGCGGCGACGGACGCGGCCCAGCGCCTCGGACTCGACGTGGCCGCCGAGATGTTCGCCCGCTACGGGCGTGACCCGCACGCACTCGACGGTGTCGGAACCGTCGTCGTCGGCAGCAACCTGGGCCTGTCCAGGGAACGCCGGCTGCACACCGGCCTGTGCCTCGACGACCTGGAGGCGGACGTCCGCTCCCTCGCCGCGCTCGCCGCACTGGGGCCGGACGACGTCGAAGCGGTGACCAAGCTGGTGCGGGACCGGTTCGGCGAGGCCGGGCCCGACGACCTGCCGACCACCTGGGACGGCTGCGTCGCCAGCGGCATCGCGGCGCTCCTCGGCAACGAACACGGCCTGGACGCCGTACCGGTGGCGGTGGAGGCGGCCTGCGCCTCCTCGCTGGCCGCCGTCGACGTGGCCGTGGGACGGCTGCGCTCCGGCGGCGCCGACTACGCGGTGGCCGGTGGCGTGGAACTTCCCTGCAACGCGCGGGACATGGTGCTCTGCTCCTCGCTGGGCCTGCTGTCGCACAGCAGGATCACCCCCTTCGACGCCGGGGCCGACGGCTTCACTCCGGGCGACGGCTGCGCGCTCTTCCTGCTCAAGCGCCTGACGGACGCCCGCCGTGACGGCGACCTGGTGTTCGGCGTGCTCCGCGCGGTCGGCGCGTCCAACGACGCGAAGTCGCTGATCGCCCCCGACGCCGACGGCCAGGCACGGGCCGTACGGCAGGCCTTCGCCCAGGTCGACTTCGGCCCGGACGAGGTGGACTACCTGGAGGCCCACGGCACCGGCACCCGCCTGGGCGACCGCGTGGAGGTCGCCGCCGCCGCACAGGTCTACGGCACGGGACGGCGTACGGCACCGCTGGACATCGGATCCGCCAAGTCCTTCCTCGGCCACACCTTCGCGGCGGCCGGGGCGGCCGGACTGCTGCGCACACTCCAGGCGTTGCGGCAGGCCACCCTGCCGCCCAGCGTCAACCTGCGCGAACTCAGCCCCGACCTCGCCCTGGACGCCGTCCCCGCGCGGGTGGCCACCGAAGCCGGGCCCTGGCCCGCCCGGGCGGGCCGGCCGCGGCGCGCCGCGGTGAGCGCGTTCGGGACCGGCGGCATCAATTACCACCTGTTGATCGAGGAAGGCACGGACGCAACGCGATGA	MSALYPGAQGVEDLWRLLLADGPAPASGTGPAPGGLGDIEVDVARFGIPPAQAASMARLQLLMVEAARQCLDDATGSGADRGRTDVVVGTCLGLDRQYANALRVDGARYARDLTEVLADGAWRDTGIDARAAGQELNDALSRRLGASPHDRVGEMASTIPARIASAFKLRGRTLAVESADATSYLALAHAVDNLRAGLAEAVLVVVGQRDEGRFARRALAAKGFAARPSEAGAGDAPVLTEGLGALLLKRRSTAERDGDRVYASVLDCALRHEARPGIFRYSLSAAHRRAAAEAAHRTADVAPGSVRLVECAGYGTAAVGRAEQEAIAGIHAGAPRDSVAVGTVRDRLGHTFANAGLAGVTKAALALHHRTVPPVLPGTDPAPTTGPFRVPRAAEPWEPSTDGTPRRAAVLGASLTGTVCHVLLEEAAPAGSVPQGAGADAHLGGARAAGAARRRFPGGQASAAGRETGAWQAEPIAIVGFGGRFADSPDADGFWRTMLSGRDRIGPLPAELFDRDLYHAPGALALGRSYTDLGAPVPVPTQPPPGLRIPPHRYAATDAAQRLGLDVAAEMFARYGRDPHALDGVGTVVVGSNLGLSRERRLHTGLCLDDLEADVRSLAALAALGPDDVEAVTKLVRDRFGEAGPDDLPTTWDGCVASGIAALLGNEHGLDAVPVAVEAACASSLAAVDVAVGRLRSGGADYAVAGGVELPCNARDMVLCSSLGLLSHSRITPFDAGADGFTPGDGCALFLLKRLTDARRDGDLVFGVLRAVGASNDAKSLIAPDADGQARAVRQAFAQVDFGPDEVDYLEAHGTGTRLGDRVEVAAAAQVYGTGRRTAPLDIGSAKSFLGHTFAAAGAAGLLRTLQALRQATLPPSVNLRELSPDLALDAVPARVATEAGPWPARAGRPRRAAVSAFGTGGINYHLLIEEGTDATR	MKDRSHDDSMAEVCRNTSENHWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEELASVEPPFTPPAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEGESLMQSWAEDRVPEALFELGFREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVTAKAFRGQGFAAAATAGWSRLSALRSRTLFYSTDRDNISSQRVAARLGLRLRGASLRISRA	360.38	gnl|BL_ORD_ID|2209|hsp_num:0	3327			531	714	kasugamycin
BGC0001063.1|Undecylprodigiosin_3 # 4048 # 5223 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0001063.1|Undecylprodigiosin_3 	4048	5223	+	Loose	1750	27.335	amrB	41.94	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACTTCGACTTCGACGCCGGGTTCGACACCGAGACCAGGGAACTGCGCGACATGGTCGTGCGGTTCGCCCGGCGCGAGCTGGACTCCTCCGGCCGTTTCGATGATGCCGAGGACTTCCGGCGGCGCTGGCTGCTGGCCGGCAAGCAGGGCCTGACCGGCACCACCGTGCCCGGTGAGTACGGCGGCAGCGGACTGGACGCGGTGTCCGCGGCCGCCACGATGGAGGCGCTCGGCTACGGCTGCGCGGACACCGGCTTCGCCTTCTCGGTCGCCGCGCATCTGTTCGCCGCCGTCATGCCGATCGTCGAGTTCGGCACCGGGGAGCAGCGTGCCGCGTGGTTGCCGGCCCTGTGCTCCGGCGAGCGGATCGCCGCGCACGCCATCACCGAGCCGGAGGCCGGTTCGGACGCGCTGCACCTGCGCACCCGCGCCCGCCCCGTCGACGACGGCCATGTGCTCAGCGGCTCCAAGTGCTTCATCACCAACGCCCCCGTGGCCGACGTGTTCGTGGTGCAGGCCGCCACCGATCCGCGGGGCGGCTTCTTCGGACTGACCACCTTCCTGGTCGAGGCATCCACACCGGGACTCACGGTGGGCCGTCCGTACGACAAGGTGGGCCTGCGCGGCTCCCCCACCGCCGACGTCCACTTCGACGACTGCTACGTCCCGGCCGGCGCGGTGCTGGGCGCCGAGGGCTCCGGGGCGAGCATCTTCTCCTCCTCGATGAAGTGGGAGCGCACCTGCCTCTTCGCGGCCTACCTCGGAGCGATGCGCCGGGTGCTGGAGTCCACGGTGGACCACGTCCGGGACCGCGAGCAGTTCGGCTCGCCCATCGGCGGCTTCCAGGCGGTCAGCCACCGCATCGTCGACATGCTGGGCCGCTACGAGGGGGCCCGGCTGCTCCTGTACCGCGCCGCCCGTTCCCTGTCCGACGGCACGGCGGACGAGGTCGGCCCGGCTCTCGCGAAGATCGCGGTCAGTGAGGCGGCCGTACAACTCGGACTGGACGCCGTCCAGTTGAGAGGTGGGCTGGGGATCATGGACGGGGAGGCGGAGACCCTGCTGCGGGACGCGCTGCCCGCCCGGATCTTCTCCGGCACCAACGAGATCCAGAAGAACAACGTCGCGCGAGCGCTGGGCCTCGGGCGCCGGCGTCCCGCGGCCCGCCGCTGA	MNFDFDAGFDTETRELRDMVVRFARRELDSSGRFDDAEDFRRRWLLAGKQGLTGTTVPGEYGGSGLDAVSAAATMEALGYGCADTGFAFSVAAHLFAAVMPIVEFGTGEQRAAWLPALCSGERIAAHAITEPEAGSDALHLRTRARPVDDGHVLSGSKCFITNAPVADVFVVQAATDPRGGFFGLTTFLVEASTPGLTVGRPYDKVGLRGSPTADVHFDDCYVPAGAVLGAEGSGASIFSSSMKWERTCLFAAYLGAMRRVLESTVDHVRDREQFGSPIGGFQAVSHRIVDMLGRYEGARLLLYRAARSLSDGTADEVGPALAKIAVSEAAVQLGLDAVQLRGGLGIMDGEAETLLRDALPARIFSGTNEIQKNNVARALGLGRRRPAARR	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	37.49	gnl|BL_ORD_ID|428|hsp_num:0	476			126	219	
BGC0001063.1|Undecylprodigiosin_4 # 5249 # 5569 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.654	BGC0001063.1|Undecylprodigiosin_4 	5249	5569	+	Loose	700	23.0978	vanS gene in vanC cluster	56.25	3002933	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGGACGTCATCATCCACCGCATTCGTCTGCACGACGGAGTGGACCCGGCCCGCTTCGAGGCCTGGGTCCGGGACGTCGACTACGCGACCTGTCCCCGGCTGCCGAGTGTGCGCGCCTTCGCCGTGCACCGGGTGAGCACGGAACAGGATGCCCCATTCCACTACTTCGAGAGCATCTCGGTGACCGGGCCGGACGAATTCTCCCGGGACATGAAAACCGAGGCCTTTCGGGACCTGGTCACCGTGTTCGACACGATGGCGACGGTCGTCGAGGAGATGAGCGGCGAACTCCTGGAACCCGGCTACCAGGCACGGCCCTGA	MDVIIHRIRLHDGVDPARFEAWVRDVDYATCPRLPSVRAFAVHRVSTEQDAPFHYFESISVTGPDEFSRDMKTEAFRDLVTVFDTMATVVEEMSGELLEPGYQARP	MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWLFCVAIGALLIWFGTTIYYMTKAIGYLNETIQATTQLIEEPSKRITLSSHLIDVQEEMNQLREKSLQDQRAAKEAEQRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEIALQKAQRLELLISEFFEITRFNLTTIVLQTETTDLSLMLEQLTFEFLPLLEEKNLNWQLNLQKNVLATVDTEKIARVFDNLIRNAINYSYPDSPLLLELVESDSIHIRLTNRGKTIPEEMIGRLFEPFYRMDSSRATATSGTGLGLPIAKEILLASGGDISAESKDETIIFNVRLPKPANN	29.36	gnl|BL_ORD_ID|904|hsp_num:0	966			882	930	vancomycin
BGC0001063.1|Undecylprodigiosin_5 # 5641 # 6294 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=9bp;gc_cont=0.650	BGC0001063.1|Undecylprodigiosin_5 	5641	6294	-	Loose	470	44.669	sdiA	33.33	3000826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGACCCGTGTCCTGGTGTGCTGCGACCGCGTCATCCTGGGCGAGGGAATTCGCGCATTGCTGGAGCGGCACGACATGAAAGTGCAGGTGGAGACCACCCAGCGCGGCTCGCTGGCCACGGCGGCGGAGACCGGGCCCGACATTCTGGTCGGCGTCGCCCCCCTCTTCACCATGGACAGCATCGACAAGCTCACGGAACTCGCACGACTCGGCAAGACGCTTTTGCTGACCAAGCCCGAGAATACCCACCGCGCATTCGAGGCGCTCCGCGTCGGAGTACGCGCCGTATTGTCGGCCGAAACGTCGGTCGAAGAACTGGTGCACGTCATCAGAACCATCACCGAAGTCAATGCCATAATCGCTCCGGAAGAGGCACAGGAAGCCCTGACGCGCTATTGGCGCAGCAAGGCCCCGAAGAACCTCCGCCCCGAACTGACCCCTCGGGAAACGGAAGTCCTCCTCTTACTGACCCAGGGCAAGACCAACACCGAGATGGCCGCGACCCTCTCCGTCTCGCCCACCACCGTCAGGTCCCACGTACACCGGATCCTGCGCAAACTGGGCGCGGCGACCCGTGCGCAGGCCGTGGCCATCGCCTACGAGTCGGGCCTCCTGGGCATCTGCCCGGGTTACGGCACTCCCGCCCGCTGA	MTTRVLVCCDRVILGEGIRALLERHDMKVQVETTQRGSLATAAETGPDILVGVAPLFTMDSIDKLTELARLGKTLLLTKPENTHRAFEALRVGVRAVLSAETSVEELVHVIRTITEVNAIIAPEEAQEALTRYWRSKAPKNLRPELTPRETEVLLLLTQGKTNTEMAATLSVSPTTVRSHVHRILRKLGAATRAQAVAIAYESGLLGICPGYGTPAR	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	90.42	gnl|BL_ORD_ID|207|hsp_num:0	228			477	720	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0001063.1|Undecylprodigiosin_6 # 6318 # 6473 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.641	BGC0001063.1|Undecylprodigiosin_6 	6318	6473	+	Loose	700	24.2534	gimA	42.11	3000463	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	gimA family macrolide glycosyltransferase	ATGGGGACCGTACGTGGCGTGCGGGCCGGCGCCGACGGTGGCAAGTCGATGCCGGGCACCTTTCTTTGCGATTCCCCCGATATGCCTCATGCGGCCAAACTTAGCACGCGTGTGCACACTTGGAGAGGGGCTTGCGAGGCCCTGGTGAGAGACTGA	MGTVRGVRAGADGGKSMPGTFLCDSPDMPHAAKLSTRVHTWRGACEALVRD	MRRGDLHETYRLDYAPHMHDPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPLFAEKVAETGAEPKLWNSTLPGPDADPDAWGTTPLDNVEPFLDDAIQALPQLIAAYEGDEPDLVLHDITSYPARVLAHRWGVPAVSLSPNLVAWEGYEEEVGRPTWEEPLKTERGRAYDARFRGWLKENGITEDPDPFVGRPDRSLVLIPKALQPHADRVDEKTHTFVGACQGDRAAEGDWRRPEGAEKVVLVSLGSSFTKRPAFYRACVEAFGALPGWHVVLQVGRHVDPAELGDVPENVEVRSWVPQLAILKQADLFVTHAGAGGSQEGLATATPIVAVPQAVDQFGNADMLQGLGVGRHLPTEEATAEALRAAGLALVEDPEVARRLKEIQAGMAREGGTRRAADLIEAELAAART	12.23	gnl|BL_ORD_ID|1924|hsp_num:0	1994			633	690	tylosin; oleandomycin; chalcomycin; methymycin
BGC0001063.1|Undecylprodigiosin_7 # 6558 # 7745 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=12bp;gc_cont=0.774	BGC0001063.1|Undecylprodigiosin_7 	6558	7745	-	Loose	400	26.1794	catB9	39.29	3002681	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGACGACCCGCAGGACAGACCACATGGCCGCGGCCGTGTCCACGTTCGCCCAGGCGCTGGAGACGGCGGCCGGGACGGCGGCGCTGAGTCCCTCCTCCCACAACTGCCAGCCGTGGGGCCTGGGCCGTGCCACGAGCACCACGGCCCGCCGGTCGGCGGCGGACCTGACCGGCGCGGACGCGGACGAGTACCTGGTCCTGGCCCTCGACCGCGAGCGGGAGCTGACGGCGCTGGCCGCGCACGCGGTGGAGATGGAGGTCAGCTGCGGCGTCTACTGGCGGATCCTGCTCCGCACGCTGGCGGCCCAGGGCTGGACGACGGCGGCGGTGCGCGTCCTGGACGGCGACGCGGACCCCGGCGCGGCGGGGCTGCCCGGCGGCGGCCGCCCGTTCGGTGCCGGATGGCCGACGGCGTGGACGCCGCTGTGCGTGGTGGCGCTGCGCCCCGGGCCGCTCTCCGGAGAACGGCCGGCCGACCTGCACGAGAGCGCCCTCGCCCGCCGCACCCACCGCGGCCCCTACGGGCGGGAGCCGGTGGCCCCCGGGCTGCTGCGCGACCTGGAGGAGCCCGCCACACCCGGAGCCACGGCACACCCGGTCCACCTCCGGCACCTGACCGAGCGGCGCGACCTGCGGGCGTTCGCGGCGTTCGTCGCCCGGCACGCGGGACGCGACTTCGGGCACCGGGCCGCCTGGCGGGAGACCCACTCCTTCGTCCGCCGGGACACCGCGGACGCGACCGCGCGGGGCGACGGGTTCACGCTGGAGCAGCTCTTCGGGCCCATGTCCCGGCCGCGCCGGGCGGCGATGCGCCTCGCGCTGGCCCCGACGACGATGCACCTGCTGGGCAAGGTCGGCTACCACCGGGTGCTGGCCGCCGGTCTCGCCGACGTCGTGCGCCGCACTCCGGCCGTGGTGACCATGGGCTTCGCCGGGCAGGCGCCCACACGGGCGGAGCAGCTCGAGGGCGGGGCGCGACTGGCCGACTACTGGTGGCGGGCGACCCGCCACGGCCTGTCCCTGCACCCCATCAGCATCGTCCTCCAGCACGACGACCTGCGCGGCCGGCTGGAGCGGGAACTCTCCCTGCCCGGCCGCACCTTCTTCGTGAGCCGGGTCGGTGTGGCCGGCTCGCCCGCGCCGCGCTCCCACCGGCGCGCGGACGCCGCCGTGCACGTGTCCTTCTGA	MTTRRTDHMAAAVSTFAQALETAAGTAALSPSSHNCQPWGLGRATSTTARRSAADLTGADADEYLVLALDRERELTALAAHAVEMEVSCGVYWRILLRTLAAQGWTTAAVRVLDGDADPGAAGLPGGGRPFGAGWPTAWTPLCVVALRPGPLSGERPADLHESALARRTHRGPYGREPVAPGLLRDLEEPATPGATAHPVHLRHLTERRDLRAFAAFVARHAGRDFGHRAAWRETHSFVRRDTADATARGDGFTLEQLFGPMSRPRRAAMRLALAPTTMHLLGKVGYHRVLAAGLADVVRRTPAVVTMGFAGQAPTRAEQLEGGARLADYWWRATRHGLSLHPISIVLQHDDLRGRLERELSLPGRTFFVSRVGVAGSPAPRSHRRADAAVHVSF	MNFFTSPFSGIPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCVRYLHPERDDVDKLVIGSFCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTEAMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWPESWLKESMQSLCSSDIEGLYLNWQSKART	189.00	gnl|BL_ORD_ID|91|hsp_num:0	106			228	312	azidamfenicol; chloramphenicol; thiamphenicol
BGC0001063.1|Undecylprodigiosin_8 # 7858 # 8643 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=9bp;gc_cont=0.770	BGC0001063.1|Undecylprodigiosin_8 	7858	8643	-	Loose	500	25.0238	APH(3'')-Ia	36.59	3002638	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	GTGCGGGAGGCGGTGTCCCTGACGGACCAGGTGGTTCTCGACGCGTCGCGTCCGCTGTGGATCACGCACCTGAGGCCGGACCCACGGCGGCTCACCCTCGCGGTGGTGTCCATCGCCCGGCTGCGCGAGCGCGGCCCGCACGGCCTTGCCGCCCTGCGGGCCCGGTATCTGACGGCCGCCGAGACGGAGCAGGCCGCGACCCTGCGCGCCCCCCGCCGGCGCCTCGAGTGGCTGGCCGGACGGCTCGCCCTCAAACACGCCGTCAGCGCCCACGGCAGACGGCACTGGGGCCTGGCCCGGGAACCCCGCACCGTCGAAGTGCGCGCCGTGAGCGGGGGGCTACAGGGCGGCCGGCCGGTCGTGGACGCGCCGGTCGAGGTGGGTCTGACGCACTCGGGGGACTTCGCCGTCGCCGTGTGCGGACCGCACGCGGTCGGCGTCGACCTGGAACACGACCGTCCCATGCCGCCGACCCTCGCCAGGCTGCTCGACGAGGAGTGCGACCCGCGGGCGCCGTCCGCCGACGCCCGGCGCCTGGCGGCCATGCCCGCCACGCTGCGCTGGACCTGCAAGGAGGCCGTGCTCAAGTACTACGGCTTCGGACTGCGGATCGACGCCGGTGAGGTCGCGCTGACCGGCTGGCTGCCGGACGGCCGCTTCACCTGGCGGCCCGGGGGCGGGCTGCTGCGCCACGCCCCCGTCGCCGAGACGCGGCGGCCGGCCGGCTGGGCCGGCGTGGTCGCCGGCCATCACCTGGCGCTGGTGGAAAGGCCGCCGGGCGGCTGA	MREAVSLTDQVVLDASRPLWITHLRPDPRRLTLAVVSIARLRERGPHGLAALRARYLTAAETEQAATLRAPRRRLEWLAGRLALKHAVSAHGRRHWGLAREPRTVEVRAVSGGLQGGRPVVDAPVEVGLTHSGDFAVAVCGPHAVGVDLEHDRPMPPTLARLLDEECDPRAPSADARRLAAMPATLRWTCKEAVLKYYGFGLRIDAGEVALTGWLPDGRFTWRPGGGLLRHAPVAETRRPAGWAGVVAGHHLALVERPPGG	MSDHPGPGAVTPELFGVGGDWLAVTAGESGASVFRAADATRYAKCVPAADAAGLEAERDRIAWLSGQGVPGPRVLDWYAGDAGACLVTRAVPGVPADRVGADDLRTAWGAVADAVRRLHEVPVASCPFRRGLDSVVDAARDVVARGAVHPEFLPVEQRLVPPAELLARLTGELARRRDQEAADTVVCHGDLCLPNIVLHPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERARFADAAFAERYGIAPDPERLRFYLHLDPLTWG	95.96	gnl|BL_ORD_ID|1773|hsp_num:0	1923			78	201	streptomycin
BGC0001063.1|Undecylprodigiosin_10 # 9609 # 10049 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=11bp;gc_cont=0.694	BGC0001063.1|Undecylprodigiosin_10 	9609	10049	-	Loose	200	23.8682	vanT gene in vanN cluster	33.33	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGACCGGACGAAACCTGATCCTCCAGCGCGTCGTCGGCGCGCTGTACATCCTCGCGGGGATAGGCAAGTTCTTCCCGCAGCTGGAGTCGGTGGAAGGGCGCCTCGACGACGCCTCGGAAGCCAACGACGGGACCGTGATCTCCGGTCCCGTCGACTGGCTGGACCGCCACCCCACCGGCGTGATGTGGTTCGTCGCCGTGGCCATGGTCGCGGCGGGCCTCGCCCTGCTCTGGAACCGCCGGGGGCTGGTGATCGCCGCCCTCTACGGCCAGTTGCTGATGCTGGTGCTGTTCGTGGTGATCCTCGTGAGCAGTGTCCCCGAGATCCTGGTGATGGACGCGGCCTTCTTCGCCGCCGCGATCTACCTCCTGTACCGGTACCACGCGTCACCGGGCGCGCGGACCGCCGCGCCCTCGGGCCCGACCCCGGAAGGCCGGTGA	MTGRNLILQRVVGALYILAGIGKFFPQLESVEGRLDDASEANDGTVISGPVDWLDRHPTGVMWFVAVAMVAAGLALLWNRRGLVIAALYGQLLMLVLFVVILVSSVPEILVMDAAFFAAAIYLLYRYHASPGARTAAPSGPTPEGR	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	20.86	gnl|BL_ORD_ID|4745|hsp_num:0	1983			741	864	vancomycin
BGC0001063.1|Undecylprodigiosin_11 # 10188 # 11411 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.764	BGC0001063.1|Undecylprodigiosin_11 	10188	11411	-	Loose	750	250.751	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	40.66	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCGACCCCTCCCTCGCCGTGACCGGGCTGGGTCTGGTGACCGCGGCCGGCATGGGCGTCGACGCCACCTGGGAGGGGGTGTTGCGCGGCCGGTCGGCGGGCGCCAGGGACGAGCGGCTCGCCGGACTGCCCGTGGACATCGCCTGTGCGGTGCCGGGCCTGCAACCGGCGCGTCACGTGGACCGGCGCAGCGTCCTGATCCACGACCGCTTCGTCCAGCTGGCGATCGTGGCCGCCCGGGAGGCCGTGGCCGACGCCGGACTCGACCCGCTGACCTGGGACGGCGCCCGGGTGGGCGTGGTCGTCGGCTGCGGGCTCGGCGGGGTGACGACGTGGGAGACCCAGCACCGGCGCCTGCTGGAGCGCGGCCCCGAAGCGGTGTCCGCGCTCCTGGTGCCGATGCTGGTGCCCAACATGGCGGCCGGGCACCTCGCGATGGACCTGCGTGCGCTGGGCCCGAACCTGGTGACGGCGACCGCCTGCGCCTCGGGCGGCACCGCGCTGGGCACCGCGGCCCGGCTGCTGCGGGACGGGACGTGCGACATCGTCGTGGCCGGTGGCACCGAGGCGGGCGTCAGCCCCCTCATGGTCACCGGTTTCGCGCAGATGGGCGCGCTGTCGCGCCGGGTCGACGATCCGGCGGCGGCGTCCAGGCCCTTCGACGCCGACCGGGACGGCTTCGTGATCGGTGAGGGCAGCGGCATGCTCGTCCTGGAGCGCGCGGCGGACGCCGAGGCGCGCGGCGCGACGGTGCGCGCGCGGCTGCTGGGCCACGGCGCGTCGGCGGACGCCCACCACGTCACCGCGCCCGACCCGGAGGGCGCCGGCGCCCTGCGGGCGATGGAGGCGGCCCTCGCCCAGGCGGGCGTCACCGGCCGCGACATCGACCACGTGAACGCGCACGGCACCTCGACCCCGCTCAACGACGCGGTGGAGGCCGCGGTGCTGGGCCGGCTGCTGGGCGACCGGGCGACCGTGACCTCGGCCAAGGGCGTCCTCGGGCACACGCTGGGCGCCGCCGGTGCGATCGAGGCGGCGCTGACCGTGCTCAGCATCGAGCGCTCCACCGTTCCCCCGACCGCGAACCTGCGACGGCGGGACCCGGCCGTCGACCTGGACGTGGTCGCCGACGCTCCGCGGGAGCAGAAGGTGGAGCTGGCGATGAGCAACTCCTTCGGCTTCGGCGGGCAGAACGCGGTCCTGGTCTTCGCCTCCCCGTGA	MTDPSLAVTGLGLVTAAGMGVDATWEGVLRGRSAGARDERLAGLPVDIACAVPGLQPARHVDRRSVLIHDRFVQLAIVAAREAVADAGLDPLTWDGARVGVVVGCGLGGVTTWETQHRRLLERGPEAVSALLVPMLVPNMAAGHLAMDLRALGPNLVTATACASGGTALGTAARLLRDGTCDIVVAGGTEAGVSPLMVTGFAQMGALSRRVDDPAAASRPFDADRDGFVIGEGSGMLVLERAADAEARGATVRARLLGHGASADAHHVTAPDPEGAGALRAMEAALAQAGVTGRDIDHVNAHGTSTPLNDAVEAAVLGRLLGDRATVTSAKGVLGHTLGAAGAIEAALTVLSIERSTVPPTANLRRRDPAVDLDVVADAPREQKVELAMSNSFGFGGQNAVLVFASP	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	97.84	gnl|BL_ORD_ID|1968|hsp_num:0	1943			84	1239	isoniazid
BGC0001063.1|Undecylprodigiosin_12 # 11408 # 11554 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=9bp;gc_cont=0.653	BGC0001063.1|Undecylprodigiosin_12 	11408	11554	-	Loose	2000	21.557	adeB	36.67	3000775	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACTCGCTGTTCCTCGTGGAACTGCTGCTCGTCATCCAGTCCGAGTTCGGCGTGAAGATCAGCGACGACGCCGCGGTCCCCACGGACACCATCGCCCACGCGGTGGCCCTGGTCGACAACGAGATCGCGGCCACCGCGTCATGA	MDSLFLVELLLVIQSEFGVKISDDAAVPTDTIAHAVALVDNEIAATAS	MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	4.64	gnl|BL_ORD_ID|800|hsp_num:0	866			777	867	tigecycline; tetracycline
BGC0001063.1|Undecylprodigiosin_13 # 12022 # 13029 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0001063.1|Undecylprodigiosin_13 	12022	13029	+	Loose	800	26.5646	adeG	27.27	3000778	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCCGGGCGTCCGTGCTGACCGGCCTCGGTTCCTGTCTGCCGTCCCGGTGCGTCACCAACGCGGAGCTGGAGCGGACGATGGACACCTCGGACGAGTGGATCCGGGCCCGTACGGGGATCGCCCAGCGCTACGTGGCCGAAGAGGGCACCCTCACCTCCGACCTGGCGGTGGGCGCGGCCGAGCGGGCACTGAAGTCCGCCCGCCTGACACCGGACGAGATCGACGCGGTCATCGTGGCCACCACCACTCCGGACCGGCCCTGCCCGGCGACCGCGCCGACGGTGGCGGCCCGGCTGGGCACCGGCCCGGTCCCGGCGTTCGACGTGTCCGCGGTGTGCTCCGGCTTCCTCTACGGACTCGCCACGGGGTCCGGTCTGATCGCGTCCGGAGCGGCGGAACGGGTCCTGGTCATCGGTGCGGAGACCTTCTCCCGCATCCTCAACCCGCAGGACCGCTCCACCTCGGTGATCTTCGGTGACGGCGCCGGCGCCGTCGTGCTGCGCGCCGGCGAGCCGGGGGAGACCGGTGCCCTCGGCCCGCTGCGGCTGGGCAGCGACGGCACCGGCGTGGACCTGATCACCGTGCCGGCCGGCGGACCGCCGCGGCCGGGCGCGGCGGCACCGGACGATCTCGCCGACCGCTACTTCACCATGGAGGGCAAGCGGGTCTTCTGGCTCGCCGTCCAGCGCATGGGCGAGTGCGCGGAGAGCGTGCTCGACCGGGCGGGCTGGCGGGTGGCGGACGTGGACTGGCTGGTCAGCCACCAGGCCAACCACCGCATCACCGCCCGGCTCGCCGACGAGATCGGCATCCCCCGCGAGCGCAGCGTCAGCAACATCGCCGAGGTGGGCAACACCGCCGCCGCCTCCATCCCCCTCGCGCTCGACCACGCGCACGCCCGGGGCACCCTCCGGCCCGGCGACCGGGTGCTCCTCACCGCCTTCGGCGGCGGCCTCACCTGGGGTGCCGCCGCCCTGACCTGGCCCGCCGTCGATCCGGTCTGA	MTRASVLTGLGSCLPSRCVTNAELERTMDTSDEWIRARTGIAQRYVAEEGTLTSDLAVGAAERALKSARLTPDEIDAVIVATTTPDRPCPATAPTVAARLGTGPVPAFDVSAVCSGFLYGLATGSGLIASGAAERVLVIGAETFSRILNPQDRSTSVIFGDGAGAVVLRAGEPGETGALGPLRLGSDGTGVDLITVPAGGPPRPGAAAPDDLADRYFTMEGKRVFWLAVQRMGECAESVLDRAGWRVADVDWLVSHQANHRITARLADEIGIPRERSVSNIAEVGNTAAASIPLALDHAHARGTLRPGDRVLLTAFGGGLTWGAAALTWPAVDPV	MSFSRKQFALSAIFVAILATGGSFMLLHENADAKAAPTAAQQAATVDVAPVVSKTITDWQEYSGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFDNPNGVLLPGLYARIRLGGGQPRPAILISPTAVGVDQDKRFVVVVDAKNQTAYREVKLGAQQDGLQIVNSGLQAGDRIVVNGLQRIRPGDPVTPHLVPMPNSQITASATPPQPQPTDKTSTPAKG	82.51	gnl|BL_ORD_ID|1125|hsp_num:0	1226			675	873	tetracycline
BGC0001063.1|Undecylprodigiosin_14 # 13089 # 13352 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=12bp;gc_cont=0.663	BGC0001063.1|Undecylprodigiosin_14 	13089	13352	+	Loose	700	26.5646	mgtA	32.58	3000462	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	mgt macrolide glycotransferase	ATGACTCCTCGGAAACTGATCACCGACTACATCGCCGACGCCTGGATGGGCGGCGACGCCGAAGGCCTGGAGCCGGACACCCCCATCGCGGAGCTGAACATCATCGACTCCGCCGCCATCTTCGACCTCGTCCACTACCTGCAGGGCGAGTTCCGCGTCACGGTGCCGCTGCCGGAGGTCACCCTGCAGAACTTCAGGTCCGTCAACGCGATCTGCGCCCTGGTCGACCGGCTCCGGCAGAACGAGGGGGGAACCGCGGCATGA	MTPRKLITDYIADAWMGGDAEGLEPDTPIAELNIIDSAAIFDLVHYLQGEFRVTVPLPEVTLQNFRSVNAICALVDRLRQNEGGTAA	MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPLLADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEPDLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYARFHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDWARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNVEVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVARTLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG	20.81	gnl|BL_ORD_ID|2293|hsp_num:0	515			951	1206	erythromycin; tylosin; azithromycin; methymycin
BGC0001063.1|Undecylprodigiosin_15 # 13349 # 15271 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=7bp;gc_cont=0.724	BGC0001063.1|Undecylprodigiosin_15 	13349	15271	+	Loose	350	30.4166	vanO	41.3	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGACCGACTCCGTCGACGCACTCCCCGACACCGCGCGGATCCGCGAACGCGTCGTGCACGTCATCGCCGCCCGCACCCTGTACGACGAGAGCCACCTGCGGCCGGAGAGCCACTTCGAGGCCGACCTCGGCATCGACTCCGTCATCATGGAGTCCGTCCTGGTCTCCGTCCGTGAGCACTTCGGCCTGTCCGCCGCGCTGCCCGCCGGCCCCACCACCATCGGCGAACTCGTCGACGCCGTGGGCGCCGCGCTCGCCGGCACCGGCGACGACCGGCCCGCACCGGCCGCCGGCCCCCTGCCGGCGGTCCCGGCGGAAGGGACCGGCGACCCCGTCACCGAGGCCGTGGTCGCGGCCGCCATGCGGCAGACCCAGTACCAGCGGCACCAGCTCGGCCTCGACGCCGACCTGGAGGGCGAACTGGGCGTCGACTCGGTCGTCCTGACCTCCGTCGTCGCCGAGGCCACCGAGCGGCTCGGGCTCACCGGCGCCGCCCCGGACGCGGCCGGCGCCACGACCCTGCGCGCCCTGGCCGACGCCCTGCGCGGCCTCGTCGCGGCGGCCCCGGGGACGGCGGTCCCGGAGGCGGCACCGGCGACGGGCGCGGCGGCCCCGGCCCCCGGCCGGAGCGGGAATGCGCCCGCGCCCGGCGCGGACGGCTGGGACCACCGCTCCATGAAGGACTTCACCGAACAGCGCGACCCCGACCTGTTCGCCAAGACCCGCAGCTTCGCCGGCTATCTGCGCTCCCGCGAGAAGGACCGCCTGTACTGGTACGGCATGCCGCTGCACTCCCGGTGCGGGAGCCGCGCCGTCATCTTCGACGAACTGGAGGGCCGCAAGCGCGAGTTCCTCATGTTCGCGTCGAACAACTACCTCGGCCTCGCCAACCACCCCAGCGTGATCGAGGCCGTCGTCGACGCCACCCGCACCTACGGTGCCACCCACACCGGCTCCCGCTTCATCGGCGGCACCAACATGCTGCACAAGGAACTGGAGCGCCGCCTGGCGGCCTTCAAGCAGCGGCCCGCCTGCATCGTCTATCCCGGCGGCTACTCCGCGAACCTCGGTGCCATCTCGGCACTGGTCAAGAGCTACGACACCCTCGTCGTCGACCGCCTCAACCACATGAGCATCGTCGACGGGGCACGGCTCTCCGGCGCCGTGCGCAAGATCTACCGGCACAACGACATGGCCGACCTGGAGCGGATCCTCAGCCGCAGCGCGGCGGAGGGCACCGGCGGCAGGCTCATCGTCGCGGACGGCGTCTTCAGCATGCACGGCGACGTGTGCGACCTGCCCGAGATCGTCCGGCTGGCCAAGGAGTACGACGCCCGCGTGATGATCGACGACGCCCACGCCACCGGTGTCCTCGGCGTACGCGGCTCCGGCACCGCCGAGCACTTCGGGCTCAAGGGCGAGGTCGACCTGGAGCTGGGCACCATGAGCAAGACCCTGGCCGGCATGGGCGGGTTCGTGGTCGGCGAGGAGGAAGTCGTCGAGTACCTGCGCTACTACTCCAACTCCTACGTCTTCGCCGCGAACATCCCCGCCGGCGTCGCCGCCGGACTGATCGCCTCCATCGACGTCATCGAGTCCGAGCCGGAACGCCTCAAGCGGCTGTGGACCAACATCGGCACGCTGCGGGACCGGCTCCTGGACGCCGGGTTCGACCTGGAGCACTCCGAGAGCGCCATCCTGCCCATCGTCATCGGCGACGAACGCCGGGCGATGGAGCTGGGCCGGGCGGTGCGCGCCCGCGGCCTGTTCTGCCAGACCGTGGTCTACCCCGGCGTGCCCCTCGGCGACGCCCGGCTGCGGGTCAGCGTCACCTGCGAACACACGCCGCAGGACCTGGAGCTGGCCGCGGAGATCTTCGTCGACGCCGCCCGCGAGACCGGCGTACTGCCGGGCACGCCCTGA	MTDSVDALPDTARIRERVVHVIAARTLYDESHLRPESHFEADLGIDSVIMESVLVSVREHFGLSAALPAGPTTIGELVDAVGAALAGTGDDRPAPAAGPLPAVPAEGTGDPVTEAVVAAAMRQTQYQRHQLGLDADLEGELGVDSVVLTSVVAEATERLGLTGAAPDAAGATTLRALADALRGLVAAAPGTAVPEAAPATGAAAPAPGRSGNAPAPGADGWDHRSMKDFTEQRDPDLFAKTRSFAGYLRSREKDRLYWYGMPLHSRCGSRAVIFDELEGRKREFLMFASNNYLGLANHPSVIEAVVDATRTYGATHTGSRFIGGTNMLHKELERRLAAFKQRPACIVYPGGYSANLGAISALVKSYDTLVVDRLNHMSIVDGARLSGAVRKIYRHNDMADLERILSRSAAEGTGGRLIVADGVFSMHGDVCDLPEIVRLAKEYDARVMIDDAHATGVLGVRGSGTAEHFGLKGEVDLELGTMSKTLAGMGGFVVGEEEVVEYLRYYSNSYVFAANIPAGVAAGLIASIDVIESEPERLKRLWTNIGTLRDRLLDAGFDLEHSESAILPIVIGDERRAMELGRAVRARGLFCQTVVYPGVPLGDARLRVSVTCEHTPQDLELAAEIFVDAARETGVLPGTP	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	184.97	gnl|BL_ORD_ID|1607|hsp_num:0	1754			564	696	vancomycin
BGC0001063.1|Undecylprodigiosin_16 # 15385 # 16983 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=13bp;gc_cont=0.740	BGC0001063.1|Undecylprodigiosin_16 	15385	16983	+	Loose	1000	150.214	almE	31.42	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGCGCCGCCACTCCCTCCGTGATACGCCTGCCACGGGACACGTCCGCGCAGCACGCGGCCCGGCCCGCCTTCGTCGGCTCCGACCCCCTGACGTACGGGGAGTTCACCGCCCGGGTCGAGGCCGTGGCCGCCCGCCTGCTCAGCCTCGGGACACGCACCGGCGACCGGATCGCGGTCTGGATGGACAAGCAGCCGCGCTACGCCGAGGCGATCGTCGCCGCCCTGGAGGCCGGGTGCGCCTACGTCCCCCTGGACGGCGGCCAGCCGGTGAGCAGGGTGCGGACCATCCTGGCGGACGCCGAACCCGTGGTCCTGTTCACCGACGCGCACCACGCCGCCCTGCTCGGGGACGACGACCTGCCGGCCTCGGTCACCACGGTCGTGGCCGTCGGCGACGCACTGCCCGACACCGTGGGCGGCATCCCGGTCGCCCCCTGGGAGAGCTGGGAGCAGGGCCGCGCCGGGCGGGTCACCCTGCTGCCCTCCCTCACCCCCGGCGACCTCGCCGCCCTCCTCTACACCTCGGGGTCCACCGGCACGCCCAAGGGGGTGCAGATCTCGCACGGCGCACTGGCCAACTTCGTGGCCTGGGCCCGCGACGAGCTGGACGTCGGCCCCGACGACGTGTTCGCGGGCCACGCCTCCTTCAACTTCGACCTGAGCACCTTCGACCTCTTCACCGCGCTGTCCTGCGGGGCCGCGGTGTGGATCGTCCCCGACGCCGCGACCAAGGACGTGACCGCGCTGGCCGAGGGCATCCGCCGGCACCGGATCACCGTCTGGTACTCCGTCCCCTCGGTCCTGCACCTGCTGACCACCTCCGCGGCGCTCACCCCCGAGCACGCCGCGAGCCTGCGCTACGTCCTGTTCGCCGGCGAGGTCTTCCCCGTCCCGCAACTGCGCGCGCTGCGTGAACTGCTCCCGCCCGGCACCCCGCTCTACAACCTCTACGGCCCCACCGAGACCAACGTCTGCACCTACCACCGGGTGCGCCCCGAGGACCTGCACCGGGCCACCCCCGTGCCGATCGGACTGCCCATCACCGGCGCCGGGACCACCGTCGTGGACGACGCCGGACGCACCGTCCGGGAGCCCGGCGCGATCGGCGAACTCCACGTCTCCGGCGTGTGCGTGACCCCCGGCTACTGGCGGCGTGCCGAGGAGCCGGTCTCCACCGCCCACTGCCGGGGCGTGCACCCCACCGGCGACCTGGTCAGTTACGAGGAGGACGGCCGGCTGGTCTACCGGGGGCGCAAGGACCGCATGGTGAAGCTCTCCGGCTACCGGGTCGAGCTGGGCGAGATCGAGGCCGCCGCGCTGCGCCACCCCGGCATCGCCGAAGCCGCCGTCCTGGTCGACGGCTCGGGACCCAAGGCACGGCTGCGGCTCTACTACACCCTGTGCGAGGGCGCCGAGCGGATCGGCCTGGTGGAGCTCAAGCAGCACTGCGCACGGCACCTGCCGACCTACATGGTGCCGCACGGCGCCGTCCGCCTGGACCGGATGCCGCTCAACCCCAACGGCAAGACCGACTACCGCCGCCTCGGTCTCGACGCCCCGCCCCGCCCGGCGGCGCCGCTCGGAACGGCCCGGTAG	MSAATPSVIRLPRDTSAQHAARPAFVGSDPLTYGEFTARVEAVAARLLSLGTRTGDRIAVWMDKQPRYAEAIVAALEAGCAYVPLDGGQPVSRVRTILADAEPVVLFTDAHHAALLGDDDLPASVTTVVAVGDALPDTVGGIPVAPWESWEQGRAGRVTLLPSLTPGDLAALLYTSGSTGTPKGVQISHGALANFVAWARDELDVGPDDVFAGHASFNFDLSTFDLFTALSCGAAVWIVPDAATKDVTALAEGIRRHRITVWYSVPSVLHLLTTSAALTPEHAASLRYVLFAGEVFPVPQLRALRELLPPGTPLYNLYGPTETNVCTYHRVRPEDLHRATPVPIGLPITGAGTTVVDDAGRTVREPGAIGELHVSGVCVTPGYWRRAEEPVSTAHCRGVHPTGDLVSYEEDGRLVYRGRKDRMVKLSGYRVELGEIEAAALRHPGIAEAAVLVDGSGPKARLRLYYTLCEGAERIGLVELKQHCARHLPTYMVPHGAVRLDRMPLNPNGKTDYRRLGLDAPPRPAAPLGTAR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	95.68	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
BGC0001063.1|Undecylprodigiosin_17 # 16984 # 23877 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=11bp;gc_cont=0.757	BGC0001063.1|Undecylprodigiosin_17 	16984	23877	+	Loose	1000	40.4318	almE	25.88	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGCCCGGAACCGCAGGGAGAAGAACGTGAGCCACGGGCCGACGGACCCGCTGCACGAGCACTGGCAGGGACCCGAACCGGAGACGGTCACGGCCCTGCTGCGGCACCGGGCGGAACACACCCCCGACGCCCTCGCCCACCGCTTCCTCACCGACACCGACGGTACGTCCGTCGCCTGGACCTACCGCGAACTCGACCTGCACGCCCGCGAGGTGGCCACCCACCTGCGGCACGCCGGGGTGGGGCAGGGCCCGGTGCTGCTGCTGCACCCGCCGGGCCTCGACTACCTCGCCGCGTTCTTCGGCTGCCTGTACGCCGGCGCCGTGGCCGTCCCCGCCTACCCGCCGGACAACGCCCGGTTCGGCCAGACCGTGCCCCGGCTCGCGGCCATCGCCCGGGACTGCGCCGCCACCCACGCCCTCACCACCCGCCGGGTCCGCGAGACCGTCGCCGCCGACGGCACCGGCCGGGTCGGCACCGAACTCGACGGCGTGCGCTGGCTGGTGACCGAGGACCTCTACACCGGCGAGTCCACCACCGCCTGGGAGGACCCCGGAGCCACGGCGCGGTCGCTGGCCTTCCTCCAGTACACCTCGGGTTCCACCGCCGCGCCCAAGGGCGTGATGGTCGAACACGGCAACCTGGTGCGCAACCTGCGCTCCATCCACCTCAGGCTCGGGCACGACGCGGACTCCGGCATGGTCTCCTGGCTGCCGCCGTACCACGACATGGGTCTCATCGGCGGCATCCTCACCCCGGTGTACGGCGGCTTCCCCGCGCACCTCATGGCGCCGATGACCTTCGTGCAGCGCCCGCTGCTGTGGCTGGAGACCCTCTCCCGCACCGGCGCCTCCACCAGCGTGGCACCCAACTTCGGCTTCGAGCAGTGCCTGCGCCGGATCACCCCCGCACAGCGGGCCGGCCTGGACCTGAGCCGCTGGCGCCTGGCGCTGAACGGTGCCGAGCCGATCCGCCCCGACACCCTCGACCGGTTCGCCGAGTACTTCGCCCCGGCCGGCTTCGACCGCACCGCGCTGCTGCCCTGCTACGGCCTCGCCGAGGCGACCCTCATGGTCACCGGCGTGCGGCCGGCCGACCCGCCGGTGGTGGAGTCCTTCGACGCGGCGGCCCTGGAGGCGGGCACCGCGCGTCCCGCGGACCCCGGCGGCGTGCGCACCACCCGCGTCGTCGGCTGCGGAGCACCCGTCGCCGACGTCGAGGTCGCGGTGGTCGACGCCGCCACCGGCCGCCGGGTCCCCGACGGCACCGTCGCCGAGATCCGGGTCAGTGGTCCCGGCGTCGCCCGCGGCTACTGGGGACGCCCCGAGGCCGCCGCCGAGGTCTTCGGCACCCGGATCGACGGCGAACCGGGCAACGCCTGGCTGCGCACCGGCGACGTCGGGTTCCGCCACGACGGCCAGCTCTACGTGGTCGGCAGGACCAAGGACGTGATCATCGTCCAGGGCCGCAACATCCACCCCCAGGACGTGGAACAGACGGCCGAACGGGTCGGCGCCGGACTGCGCGCCGGGTACGGCGCCGCGTTCGCCGTCCCCACCGCCGACGGCGAACAGCTCGCCCTCGCCTACGAGATCGGCGGCCCCGGCGCCGGGGATCCGCACGCCCTGCTCGCCCGGCTGCGCACCGCCATCGCCGACGAGCACCAGGTGACACCGCACACCGTCGTGCTGCTCAAACGCTCCTCGGTGCCGCGCACCACCAGCGGCAAGATCCAGCGCGGCGCCTGCCGGCAGCGCCTGCTCGACCTGGAACTGCCCGTGGTGGCCGCGAGCGTCGTCCAGGACGGTGCCCTGCCGGACACCCCCGCCCCGCACGCCCCCGCCTCCCCGGACCGTACGGCCGCCCTCGTCGCCGACGCCCTCGACCGCGCCGCGACGGACGCGCCCGACGGCACCTCGCGCTACCCGCGGCTGCTGACCGCCGTACGGACGCTGTCCGAGCGCCTCGGCGTCGCCCTCGACGTCGGTGAACTCCTGTCCGGCCCCGAGCCGGACGGCGCGCCGTCCCTCACCGGGCTGTGCCGCGCCGCGCTCGCCGACGCGGCGCCCGCGCCCACGGCCGCGCCGGAGCGGACCCGGACCCAGGCCGTGGACTGGCTGCGGCGGGCCGTCGCCGCCCGGCTGGGCCTGCGCCCCTCGGTGATCGACACGGCGGTCCCCTTCACCTCACTGGGCCTGGACTCCAAGCAGGCCGTGGCCCTCACCGCCCCGTTCGGCGACTGGCTCGGCACCCCCGTGACCCCGGCCACCCTCTACGACCACCCGACGGTCGAGTCCCTGGCGGCCCACGTCACCGGACCAGAGGCGGACGGCACCCCGCACCCGCACCCGCGGCGTCCCGCTCCCGAGCCCGCCCGCGGGCGCGCCGACGAGCCCGTCGCCGTGATCGGCATCGGCTGCCGGTTCCCCGGCGCACCCGACCCCGACAGCTACTGGCGGCTGCTGCGCGACGGCCGCGACGCCGTGGGCGAGGCACCCGCCGACCGCCACGGCGACACCGGCGGCCGGCCGGGCGGCTTCCTGGAGCACGTGTACGACTTCGACGCCCGCTTCTTCGGCGTCTCCGCCCGCGAGACCGAACGCATGGACCCCCAGCAGCGGCTGCTCCTGGAGGTCGCCTGGCAGACCTTCGAGGACGCGGGCATCGCGCCCTCCTCCCTGGCCGGCACGGACACCGGTGTCTTCGTCGGCATCAGCGGGCACGACTACGCCGATCTCCAGATGCCGCACCCCGACGTCGTCGACATGTACTCCGCCACCGGCAACGCCCAGTCCGTGGCGGCCGGCCGGCTCTCGTACTTCTTCGACCTGACCGGGCCCAGCCTCGCCCTCGACACCGCCTGCTCCTCCTCGCTCGCCGCCGTCCACACGGCGCTGCGCAGCCTGCGGGACGGCGAGTGCGGCGTCGCCCTCGCGGGCGGCGTCAACCTGATGCTGACGCCCGGGCTGTCGGAGGCCCTCGCCCGGGGCGGCATGCTCGGCCCCGGCGGACGCTGCCGCACCTTCGACGACGGCGCCGACGGCTACGTCCGCGGCGAGGGCGCGGGCCTGGTGTGCCTCAAGCCGCTGTCCGCCGCGCTGGCCGACGGGGACCGCGTGCACGCCGTGCTCACCGGCTCCGCGCTCGGTCACGGCGGCCGGGCCAACGGCCTGACCGCCCCCCGCAGCACCGCCCAGCGTGCCGTGATGACCGGGGCGCTGGAGCGGGCCGGTGTGCAGCCCGGACAGATCGACTACGTCGAGGCACACGGCACCGGCACCGCTCTCGGCGACCCCATCGAGTGGGAGGCCCTGGCCGGCGTCTACGGCCGCGGCCGCCCCGCCGACGCGCCCTGCCCGGTCGGCTCGGTGAAGACCGCCATCGGCCACCTGGAGGCGGCCGCCGGCATCGCCGGGCTGATCAAGGCCGTGCTCGTGGTGCGGGAGCGGGAGGTACCGCCGCTGCTGCACCTGGCCACCCCCAACCGGCACCTGGACTGGACGGGTTCGGGACTGACCGTGCCCACCACCCGCCGGGCCCTGCCCGCCGGGGGCACCCTGCGCGCGGGCGTCAGCTCGTTCGGCTTCGGCGGCACCAACGCCCATGTGATCGTCGAGTCCGCGCCCGCACCCCCGGCGCCCGCCGGCGAGTCCGGCGCCCCCGACGGCACGGTGCACGCCCTGTCCCTGTCCGCGCACACCGAGTCCGCCCTGGCCACCCTGGCCGGCCGCTACCGCACCCACCTCGCGGCCCACCCCGGCGTGCCGCTCGCCGCCCTGTGCCACTCCGCCCGCACCGGCCGTTCCCGGCTGCCGCACCGGGCGGTCCTCACCGCAGCGACCCGGGACGAACTGGACACCGCACTGGAGGCGCTGATCCGCCGGGAGCCCGCCGTGGACGTGGCCCGCGGCGGACCCGCGGACGGCACCGCGCCCACCGTCGCCTTCCTCTTCGGCGGCCAGGGCACCCAGTACCCGGGCATGGGCCGCGACCTCTACGACGCCCACCCCGTCCTCGCCCGCACCCTGCGGCGCGCCGACGCGGTGCTGCGCGGCCTGGGCGAGATCCCGCTGCTCGACCTGCTCTTCGACCCGGACCGCGCCGAGGACCTGGCCCGCACCCGGTACTGCCAGCCCGCCCTGGTCGCCCTCGAAGTCGCCCTCGCCGACCTGTGGACGAGCTGCGGAGTACGCCCGGCGGCCGTGCTCGGGCACAGCGTCGGCGCCCTCGCCGCCGCCTGCGTCGCCGGTGTCCTCTCCCTGGAGGACGCCCTCACGCTGGCGGTCGTCCGCGGGCGTGCCATGGACGAACAGCCCGGCGAGGGCGCGATGATCGCCTGCGTCGGCGATCCGGAGACGGTGCGCGAGATCGCCGCCGGCCACGACCGGGTGGCCCTCGCCGCCGTCAACGCGCCCCGCAACCTGGTGTTCTCCGGCGCGGCCGACCGGATCGCGGCACTCCGCGGCGACCTGGAACGCAAGGGGGTCACCGTCCGGCCGCTCGCCGTCTCGCACGCCTTCCACTCACCGCTGATGGCGGGCGCCGCCGAGCCGCTGCTGGAGGCCGCGCGCGCCGTCGAGTTCCAGCCCCCGGCCATCCCGTGGATCTCCGACGCCACCGGCGAACCCGTGACCCGGGTCGACGCCGAGTACTGGGTCCGCCACCTGCTCGGCACCGTGCGCTTCGCCGACGGCTTCGCCCGCCTGCGCGCGGGGAACGCCGAAGGCGGTCTGGGCTGCGACGCGTTCGTCGAGATCGGCCCGCACCCCACCCTGCTGAACCTCGGCCGGTCCGCCGTCGCCGACGGCCCCGAGCCCGACGGACGCCGCACGCTGTGGCTGCCCTCGCTGCGCCGCGGCGCCCCCGGCCGCCGCACCCTGCTGCGGTCGCTGGGCGGCTACCAGTGCGCGGGCGGAGACATCGACTGGTCCGCCCTGGACGACGAACACCCGCCCGCCCGGGTCCCGTTGCCGCACACGCCCTTCGAACGCCGGACCTACCGGTTCCAGGCCCCCACTCCCGATCAGGAAGGCGATCCCATGCCGTCCCAGCCCACGGTGCCGGGCACCGCCCCGACGGGCCCCGCGGGCGAGGTCTCCCGCACCGTGCTCGACACCGTCGCCCGCGTCTGCGGATTCCCCGTGGCCGACCTGCCGGTGCACGCCAGGCTCGGCCTCGAGCTGGGATTCGACTCCCTGATGCGGACCGACCTCCAGCGCCGTCTCACCGACCGCTTCCCCCAACGGATGCACACGCTCCAGGACCTGCCGGAGGACCCCACGGTGCAGGACATCATCGGCCGGCTCGCCGCCGGCGACGACCGCGACGGCGACCCCGCCGGCGGCGCCCACACCGCCCGCCCCGCCCTCGCCGGCACCGGCCCGGCCGCGCCGCCGGCCCACCCCGCGGCCGTACCGGCGGCGCCGCCCGTCCCGGCCCCGCAGTACGCCCCGTACGGAGCCTTCCCGGCCCCGCCCCACGGCTACGCCGTCGCCGCCCCGGTCCCGCAGCCCGGAGTGCCGTACCCGTACCCGTACGGCTACCCGCCGCACGGTGCTCCCGGGTACGCCTACTACGTCCCCCAGCCCTACCCCCCGCAGGCGTTCCCGCCCCCGGCACCCCCCTCCCCGCTGCAGGCGGCCCCCGCCCCCGTACCCGCCGCAGCCCCCGCCCCCGTTCCCGACCCGGTTCCGGCGCCCGCCGCCCCCGTACGTCAGGAGCGCGCCTTCGAGGACTGGGCGGAGTACGCGGAACTCCAGGGCAGACTCCGCCAGACCCGGACCAGCGGGTCCAACCCCTACGGCCGTACGCACGAGGGCTTCAACTCCGCGCTCGCCACGGTCGACGGCACCAAGGTCGTCAACTTCGCGGCCTTCAACTACCTGGCGCTCTCCCACCACCCCCGCGTGCGCCAGGCGGCCAAGGACGCCGTGGACCGCTACGGCACCTCCGCCTCCGCCACCCCGCTGCTGTTCGGCGAGACCCCGCTGCACCACGAACTCGAAGCCGAGATAGCACGGTTCATCGGTACCGAGGCGGCCATCGTGTTCGCCGGCGGCCACGCCACCAACGTCGCCACCGTCGGCCACCTGTTCGGCCCGGAGGACCTGGTGGTGCACGACGCCTGGATCCACGACAGCACCGTGCGCGGCTGCATCCTCTCGGGCGCCCGGCGCCGGTCCTTCCCGCACAACGACTGGGCCGCCCTCGACCGCATCCTGACCGGAGCACGGGCCTCGCACCGCAGGGCGCTCGTCGTCATCGAGGGCGCCTACAGCCAGGACGGCGACATCCCCGACCTGCCGCGCTTCATCGAGGTCAAGAAGCGCCACGGCGCCATGCTGATGATCGACGAGGCGCACTCCATCGGCGTCCTGGGCCGCACCGGCCGCGGCGTGGGCGAGCACTACGGCACCGACCCGGCCGACGTCGACCTGTGGATGGGCACCCTCAGCAAGGCGCTGGGCAGCCTCGGCGGGTACATCGCCGCCCGCCGCCCGATCATCGAGTACCTCAAGTTCACCGCGCCGCTGCACATCTTCTCCACCGGCATCTCCCCGGCGAACGCCGCCGCCGCCCTGGAGGCGCTGCGGGTCGTCCAGGACGAGCCCGAGCGGGTCGCCCGGGTGCAGGAGCTGGCCGAGTTCTTCCGCGCAGGCGCCCGCGCCCGCGGCCTCGACGTCGGCGTCTCCCGCCTCTCCGCGGTGATCCCGGTGATCACCGGTGACTGGGAGAAGACGATGGCGCTCTCCAACTCGCTGCTGGAGCGCGGCGTCAACGTCATGCCGATCGGCTACCCCGCCGTCCCGCGCGACCAGTGCCGGCTCCGCTTCTTCATCAACGCGGACCACAGCGAAGCAGACCTCGAACACTCCCTCGACCTCCTGGTGTGA	MARNRREKNVSHGPTDPLHEHWQGPEPETVTALLRHRAEHTPDALAHRFLTDTDGTSVAWTYRELDLHAREVATHLRHAGVGQGPVLLLHPPGLDYLAAFFGCLYAGAVAVPAYPPDNARFGQTVPRLAAIARDCAATHALTTRRVRETVAADGTGRVGTELDGVRWLVTEDLYTGESTTAWEDPGATARSLAFLQYTSGSTAAPKGVMVEHGNLVRNLRSIHLRLGHDADSGMVSWLPPYHDMGLIGGILTPVYGGFPAHLMAPMTFVQRPLLWLETLSRTGASTSVAPNFGFEQCLRRITPAQRAGLDLSRWRLALNGAEPIRPDTLDRFAEYFAPAGFDRTALLPCYGLAEATLMVTGVRPADPPVVESFDAAALEAGTARPADPGGVRTTRVVGCGAPVADVEVAVVDAATGRRVPDGTVAEIRVSGPGVARGYWGRPEAAAEVFGTRIDGEPGNAWLRTGDVGFRHDGQLYVVGRTKDVIIVQGRNIHPQDVEQTAERVGAGLRAGYGAAFAVPTADGEQLALAYEIGGPGAGDPHALLARLRTAIADEHQVTPHTVVLLKRSSVPRTTSGKIQRGACRQRLLDLELPVVAASVVQDGALPDTPAPHAPASPDRTAALVADALDRAATDAPDGTSRYPRLLTAVRTLSERLGVALDVGELLSGPEPDGAPSLTGLCRAALADAAPAPTAAPERTRTQAVDWLRRAVAARLGLRPSVIDTAVPFTSLGLDSKQAVALTAPFGDWLGTPVTPATLYDHPTVESLAAHVTGPEADGTPHPHPRRPAPEPARGRADEPVAVIGIGCRFPGAPDPDSYWRLLRDGRDAVGEAPADRHGDTGGRPGGFLEHVYDFDARFFGVSARETERMDPQQRLLLEVAWQTFEDAGIAPSSLAGTDTGVFVGISGHDYADLQMPHPDVVDMYSATGNAQSVAAGRLSYFFDLTGPSLALDTACSSSLAAVHTALRSLRDGECGVALAGGVNLMLTPGLSEALARGGMLGPGGRCRTFDDGADGYVRGEGAGLVCLKPLSAALADGDRVHAVLTGSALGHGGRANGLTAPRSTAQRAVMTGALERAGVQPGQIDYVEAHGTGTALGDPIEWEALAGVYGRGRPADAPCPVGSVKTAIGHLEAAAGIAGLIKAVLVVREREVPPLLHLATPNRHLDWTGSGLTVPTTRRALPAGGTLRAGVSSFGFGGTNAHVIVESAPAPPAPAGESGAPDGTVHALSLSAHTESALATLAGRYRTHLAAHPGVPLAALCHSARTGRSRLPHRAVLTAATRDELDTALEALIRREPAVDVARGGPADGTAPTVAFLFGGQGTQYPGMGRDLYDAHPVLARTLRRADAVLRGLGEIPLLDLLFDPDRAEDLARTRYCQPALVALEVALADLWTSCGVRPAAVLGHSVGALAAACVAGVLSLEDALTLAVVRGRAMDEQPGEGAMIACVGDPETVREIAAGHDRVALAAVNAPRNLVFSGAADRIAALRGDLERKGVTVRPLAVSHAFHSPLMAGAAEPLLEAARAVEFQPPAIPWISDATGEPVTRVDAEYWVRHLLGTVRFADGFARLRAGNAEGGLGCDAFVEIGPHPTLLNLGRSAVADGPEPDGRRTLWLPSLRRGAPGRRTLLRSLGGYQCAGGDIDWSALDDEHPPARVPLPHTPFERRTYRFQAPTPDQEGDPMPSQPTVPGTAPTGPAGEVSRTVLDTVARVCGFPVADLPVHARLGLELGFDSLMRTDLQRRLTDRFPQRMHTLQDLPEDPTVQDIIGRLAAGDDRDGDPAGGAHTARPALAGTGPAAPPAHPAAVPAAPPVPAPQYAPYGAFPAPPHGYAVAAPVPQPGVPYPYPYGYPPHGAPGYAYYVPQPYPPQAFPPPAPPSPLQAAPAPVPAAAPAPVPDPVPAPAAPVRQERAFEDWAEYAELQGRLRQTRTSGSNPYGRTHEGFNSALATVDGTKVVNFAAFNYLALSHHPRVRQAAKDAVDRYGTSASATPLLFGETPLHHELEAEIARFIGTEAAIVFAGGHATNVATVGHLFGPEDLVVHDAWIHDSTVRGCILSGARRRSFPHNDWAALDRILTGARASHRRALVVIEGAYSQDGDIPDLPRFIEVKKRHGAMLMIDEAHSIGVLGRTGRGVGEHYGTDPADVDLWMGTLSKALGSLGGYIAARRPIIEYLKFTAPLHIFSTGISPANAAAALEALRVVQDEPERVARVQELAEFFRAGARARGLDVGVSRLSAVIPVITGDWEKTMALSNSLLERGVNVMPIGYPAVPRDQCRLRFFINADHSEADLEHSLDLLV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	413.13	gnl|BL_ORD_ID|4935|hsp_num:0	5928			1167	1410	colistin A; colistin B
BGC0001063.1|Undecylprodigiosin_18 # 23881 # 24924 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0001063.1|Undecylprodigiosin_18 	23881	24924	+	Loose	1200	38.1206	arnA	27.96	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGTCCTCACTCAGCCAAGACAGCCCGTCCGCCGCCGCCCCCGACATCCTGGTCACCGGCGCCAGCGGCTTCATCGGCGGTCACCTGGTGCACCGCCTGGCCGAGCGCGGGCACCGCGTCCGCGTCCTGGCGCGCTCCACGAGCGACCGCGCGGCCTTCGCCGGGGCCGCCGCCCAGGTCACCGTCGGCGACCTCGGTGACACCGACAGCCTGCGCCGGGCCACCACCGGAATCCGCCACGTCTACAACTGCGCCGGACTCTCGGCCGACTGGGGTCCCTGGGACCGGTTCCGCGCGGTCAACGTGGACGGCGCCAGGAACCTCGTCGAGGCGGCCCACGAGGCCGGGACGGTCGAGCGCCTGGTCCACCTCAGCACCACCGACGTCTACGGCTACCCCGAGCGGCCCTGCGACGAGAGAACCGCCCCGCGCGACATCGGCCTGCCCTACAACCGCAGCAAGATGCTCGGCGAGGCCGCCGTGTGGGCCGCCGCCGAACGCACCGGCCAGCCGGTCACGGTGGTCCGCCCCGTCTCCGTCTACGGCCCCGGCAGCAAGGACTTCGTGATCGAGATCGCGAACCTGCTGCTGGGCAAGCAGATGGTGTACATCCGCGGCGGCCGGGTGCCCGCCGGGCTGCTCTACGTCTCCAACGCCGTGGACGGCATCATCGCCGCCGCGACCGGCGAGCACACCGCGGGCCGGGCCTACAACCTGCGCGACCCGCACGACACCACCTGGCGCGAGTACGTCGAGGCACTCGCCGAGGGTCTGGGCGTCAAGGCCCCCTGGCTGAGCCTGCCCACGCCCGTCGCCACCGCCGTCGCCACCGTCTCCGAGAAGCTGTGGGGCGCCCTGCGCATCGACTCCCGGCCCGTGCTGACCCGGCACGCCGTCCACCTCTTCGACCGCGACCAGTCCTACCCGATCGGGCGCGCCCAGGAGGAGCTGGGCTTCAAGGGCGAGGTCGACTTCCAGGAGGGCATGCGGCGCACCGTCGCCTGGCTCGACTCGCCCGAGGGACGCGCCCATGTCGCCCGCTGA	MSSLSQDSPSAAAPDILVTGASGFIGGHLVHRLAERGHRVRVLARSTSDRAAFAGAAAQVTVGDLGDTDSLRRATTGIRHVYNCAGLSADWGPWDRFRAVNVDGARNLVEAAHEAGTVERLVHLSTTDVYGYPERPCDERTAPRDIGLPYNRSKMLGEAAVWAAAERTGQPVTVVRPVSVYGPGSKDFVIEIANLLLGKQMVYIRGGRVPAGLLYVSNAVDGIIAAATGEHTAGRAYNLRDPHDTTWREYVEALAEGLGVKAPWLSLPTPVATAVATVSEKLWGALRIDSRPVLTRHAVHLFDRDQSYPIGRAQEELGFKGEVDFQEGMRRTVAWLDSPEGRAHVAR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	52.42	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1491	polymyxin B
BGC0001063.1|Undecylprodigiosin_19 # 24911 # 25753 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0001063.1|Undecylprodigiosin_19 	24911	25753	+	Loose	400	27.7202	ErmQ	22.62	3000593	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCGCCCGCTGACCTGCTCTCCCAGCGTTCCGCCTGGTTCCCCCGCCCCGTCGCGGCACCGGCCGCCGAGCCGCCCGACCCGGCGGCCGCCCCGCTGCGCCTGGTCTGCTTCCCCTACGCCGGGGGGACGGTCTCCGCGTTCCGCGGCTGGCAGGAGCGGCTGGGCGACGAGGTCGCCGTCGTACCCGTACAACTGCCCGGCCGCGGACTGCGCCTGCGCGAGCGGCCGTACGACACCATGGAACCCCTCGCCGAAGCGGTCGCGGACGCGCTGGAGGAGCACCGGCTCACCCACGACTACGCCCTGTTCGGGCACAGCATGGGCGCCCTGCTCGCCTACGAGGTGGCCTGCGTGCTGCGCCGGCGCGGGGCACCGCGGCCCCGGCACCTGTTCGTCTCCGGCAGCCGGGCCCCGCACCTGTACGGCGACCGCGCCGACCACACCCTGTCCGACACCGCCCTGCGCGAGGTCATCCGGGACCTGGGCGGCCTCGACGACGCGGACACCCTGGGCGCCGCCTACTTCGACCGCAGACTCCCGGTGCTCCGCGCCGACCTGCGCGCCTGCGAGCGCTACGACTGGCACCCCCGGCCACCGCTGGACTGCCCGACGACCGCGTTCTCCGCCGCCGCCGACCCCATCGCCACCCCGGAGATGGTCGAGGCCTGGCGGCCCTACACCACCGGCTCGTTCCTGCGGCGCCACCTGCCGGGCAACCACTTCTTCCTGAACGGCGGCCCGTCCCGCGACCGGCTGCTCGCCCACCTGGGCACCGAACTCGACGCCCTCGGCACCACCCCGCACAGGAAGGCAACTAGGGAAGCAACATGGACATTCTGA	MSPADLLSQRSAWFPRPVAAPAAEPPDPAAAPLRLVCFPYAGGTVSAFRGWQERLGDEVAVVPVQLPGRGLRLRERPYDTMEPLAEAVADALEEHRLTHDYALFGHSMGALLAYEVACVLRRRGAPRPRHLFVSGSRAPHLYGDRADHTLSDTALREVIRDLGGLDDADTLGAAYFDRRLPVLRADLRACERYDWHPRPPLDCPTTAFSAAADPIATPEMVEAWRPYTTGSFLRRHLPGNHFFLNGGPSRDRLLAHLGTELDALGTTPHRKATREATWTF	MKAKSNNYRGKVDISVSQNFITSKNTIYKLIKKTNISKNDFVIEIGPGKGHITEALCEKSYWVTAIELDRSLYGNLINKFKSKNNVTLINKDFLNWKLPKKREYKVFSNIPFYITTKIIKKLLLEELNSPTDMWLVMEKGSAKRFMGIPRESKLSLLLKTKFDIKIVHYFNREDFHPMPSVDCVLVYFKRKYKYDISKDEWNEYTSFISKSINNLRDVFTKNQIHAVIKYLGINLNNISEVSYNDWIQLFRYKQKID	108.95	gnl|BL_ORD_ID|272|hsp_num:0	303			510	732	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001063.1|Undecylprodigiosin_20 # 25741 # 26829 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=5bp;gc_cont=0.723	BGC0001063.1|Undecylprodigiosin_20 	25741	26829	+	Loose	550	33.4982	RlmA(II)	29.79	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGACATTCTGAGCCTGGCCAAGAGCGTCGGCAGCCGCGTCGAGGCGCCGCTGACCGACCTGCGCACCGTGACCAAGGTGCTCGGCAATCCGCACATGCCGCTGCTCCTGGCCCTGTCCAAGGGCTTCGTCGAGCCGGTGTACCGGGCCGCCTTCCTGGCCTCGGCGGCGAGTTCCGGCGTGCTCGCCGCCCTCGCCGTACGCCCCTGCGACCTGGAGTCGCTGGCGGAACGGCTCGACATCGACGACGAGGACCTGCCGCGCCTCAAGGAGTGGCTGGACATGGGCATCCGCCTCGGCGACCTGGGCAAGCGCGAGGGCTGCTACAAGCTGCGCAGCCTGCCCGCCAAGGCGCTCGCCCAGCCCGGCAACGACGCGATCGCCGCCGCGCTGGAGGAGGTCCTGCGCTTCCACGTGCCCGCACTGCTGAACGGCCCCCGCATGCTGCGCGAGGGCCGCCGCTTCTCCCTCGACGACCAGGACGGCCTGGTCATCGCCCGCTCCACCCGGGTGATCCAGCCGCTGGTCGAGGAGGCCATCGCCCGCACCCTGGACCGGAACGCGCCCGTACGGCTCCTGGAGGTCGGCTGCGGCAGCGGCACCTACGTCCGCTACGCCGCCGAGCTCAACCCCCGCCTGTCGGCGCTCGCCGTCGACCTCCAGCAGGACGTGGCCGACAGCGCCGCGGCGAACATGGCCGAGTGGGGGCTGACCGACCGGGTCGAGACCCGGCAGGCCGACCTGCGCACCCTCGACGCGCAGCCCCAGTTCGACCTGGTCACCCTGCACAACAACATCTACTACTTCCCCGAGGCCGAGCGGGTCGAGGCCCTGCGCCGGGCCCACGACCTGCTGGCACCCGGGGGCAGGCTGCTGCTCACCACCTCCTGCAAGGGCGGGAACGTCGGTCTGGAAGCGCTCAACCTCTGGTTCACCTACGCCGACTTCGGCGGCCCGCTGCCGCAGGCCGACGCACTGGCCGACCAGCTCCGCCAGGCCGGGTTCGACGACGTCGAGGCCACCCGGATCGTCCCGGGCGAGCAGTTCCACGCCTTCACGGGCACCAGCAAGCGCGTCGCGCACGCCTGA	MDILSLAKSVGSRVEAPLTDLRTVTKVLGNPHMPLLLALSKGFVEPVYRAAFLASAASSGVLAALAVRPCDLESLAERLDIDDEDLPRLKEWLDMGIRLGDLGKREGCYKLRSLPAKALAQPGNDAIAAALEEVLRFHVPALLNGPRMLREGRRFSLDDQDGLVIARSTRVIQPLVEEAIARTLDRNAPVRLLEVGCGSGTYVRYAAELNPRLSALAVDLQQDVADSAAANMAEWGLTDRVETRQADLRTLDAQPQFDLVTLHNNIYYFPEAERVEALRRAHDLLAPGGRLLLTTSCKGGNVGLEALNLWFTYADFGGPLPQADALADQLRQAGFDDVEATRIVPGEQFHAFTGTSKRVAHA	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	128.37	gnl|BL_ORD_ID|2052|hsp_num:0	2274			294	435	tylosin; mycinamicin
BGC0001063.1|Undecylprodigiosin_21 # 26852 # 29653 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0001063.1|Undecylprodigiosin_21 	26852	29653	+	Loose	1500	270.396	rphB	28.37	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGGACACGCACGTCAGCGACACGACGACCCCCGCCGGAGCAGGCGAAGGCCCCGCCGGCCCGGTCACCGACCCGGCCGGGCACGCCGCCTGCGTCGTCACCCTGGGCGCGGGCGGCCCGACCGGAGGCCACCGGGGGGAACTGGGCGGCAAGGGCACCCGCCTCGCGGAGCTGTCCGCCGCGGGTCTGCCCGTCCCGCCCGCCTTCTGCCTGACCACCGCCCTCTTCGACGCCTACCTGCGGGAGACCGGGATCGCCGCCGAGGCGGCGGGCGCCGACCCCCGCACCCTGCGCGAGCGCATCCTGGGCACCCGGATGCCCGCCTCGATCGCGGACGCCGTCCTCGACGCCTACGGCAGCATGGGCCGCCCCCGCGTGGCGGTGCGCTCCTCCGGACTGCGGGAGGACTCCGCTGCACAGTCCTTCGCCGGCCAGCACGACACGGTCCTCGACGTCTGCGGCGACGAGGACGTACTGGACGCGGTCCTGCGGTGCTGGGCCTCGCTGTGGTCCGACCGCGCCACGGTGTACCGGGACACGGACGCCCCCGACGCCCTCGCCGTGGTCGTCCAGGAGATGATCCACACCGACGTCAGCGGCGTGATGTTCACCGTCGACCCGGTCAACCCCCGCCCGCACCGCCTCGTGGTGGAGGCCTGCCAGGGCCTGGGCGAAGGGCTGGTCTCCGGGCAGGTCTCCAGCGACTTCTTCGTCGTCGACGACGAGAAGCTGGAGGTCGTCGAGGAACGGGTCCGCTACAAGGTCACCAAGTGCGCGCCCCTGGAGCCCGGCCGCATCGGCATGACGAAGGTCGACGCGGCGGCCCGCAGCGTCCCCTGCCTCACCCACGACCAACTGCGCGAACTCGGCGCCCTGGCCGTCCGCATCCGCGACCTGTACGGCAGCGAGCAGGACATCGAGTGGGGCGTGCGCGACGGCGTCTTCCACCTGTTCCAGACCCGCCCGATCACCACCCGGCCCGCCGCCCCCGCGGCCCCGTCCGGCGCGCTCAGCCCGTACGTCGCCCCGCAGCCGGAGCCGGTCCTCAACGGCACCCTGTGGTCGCGCATGGACATCGGGGAGATCTTCGTCGGCCTGATGACCCCGCTCGGCCTGAGCTTCGCCCGCTACTACCAGCGCAACGTGCACACCGACTGCGCGGGCGCCCTCGGCGTGCGCGACACCGGCGAGGCCGACCTGCACATGGGCTTCTACCAGGGCCACGTCTACCTCAACATCTCCTACAGCTCCTACCTGTTGGCCCAGTGCCTGCCCACCCGCGACCAGCGCCACTTCACCAGCCGCTTCGTCAGCGAGGAGGTCGACCTCGCCGACTACGAGAACCCGTTCGGCACCTTCCCCGGCGGCATGGAGGACCTGCTCTCCACCGTCCACTGGCTGCAGCACACGGCCCGTGAGATGACGCAGATGAAGTCCCGCTCCCAGCAGATGGTCGACGCCCGGCTCTACGAGTTCGACCGGGCCCGCGGCCTCGACCTGACCCGGATGAGCAGGCGCGAACTGCACGGCGAACTCCACCGCGACCTCGCCTGGTTCCACGACATGCACATCGGCTACATGCCGTACTACATCAACGCGTTCGCCTTCTACGGCCTGCTCACCGAGCTGTGCGCCCGCTGGCTCGGCAGCGACGGCGTGGGCCTGCAGAACCGCGTCAAGACCGACATGTCCAGCCTGCGCACCGTCGAGTCGGCCAAGGAGGTCTGGTCGGTCGCCCAGGCCGCCAAGAACGACCCGGCCGTCCTGCGGATCATCAAGGACGAACCGCTGGAGGACATCGCCCGGCTGCTGCGCGAGGACCCCGCCGGACAGCGCTTCTGGGACCGGCACATGGAGCCGTTCCTGCGCGCCAACGGCACCCGCGGCCACCAGGAGATGGAGATCACCCACCCGAGGTGGATCGACGACCCCTCCTACATCTTCCAGATGATCCGGCGCTACGTCGCCGACGGCTTCTCCATCGACGACATCCTCCGCCGCAGCAGCGGCTGGTCCGACGACTCCCGCGAGGTGCTGGGCCGGCTGCCGATGCCCAAGCGCCAGGTCCTGGACACCGTCATCTCCCTCTACGCCCTGTGCAGCGAGCTGCGGGAGACCACCCGGATGTCCATGATCACGTCCATCTGGCTGGTGCGGAACGTGGTCTACGAGGTCGGCCGGCGCCTGGTCGCCGACGGCGTCCTGCACTCCCCGGACGAGATCGCCCACCTGGACTTCGAGGACGTGCGCCGCTACCTCGCCGGCGACGAGGACGCCGTACGCGTCTTCGACCGGGCCCGCATCGACGCGGCCCGCCGGCTGCACGAACACAACAAGCGGCTCCCGGAACCGCCGTTGACCTTCGTCGGCGTCCACGACATCACCGCCTCGGTCCGGCCCGCCGCCGACGGCGCCCGGCTCGAAGGCCTCGCCGCCAGCCCCGGACGGATCGTGGGCCGCGCCCGCATCGTCGAGGACCTGGTGTGGCAGGCCGACGAGTTCGAGGCCGGGGAGATCCTCGTGACCGGGTACACCGACGCCTCCTGGACGCCGCTGTTCGCCATCGCGGGCGGGGTCGTCACCGACATCGGGTCGATGCTCTCGCACAGTTCCATCGTGGCCCGCGAGTTCCACGTCCCGTCGGTGGTGAACACCAAGGACGCCACCCAGCGCATCAACACCGGCGACCTGATCGTGGTGGACGGCGACGCGGGCACGGTCGAGGTCGTCGAGAGCGCGGACACCGACCCGCAGGGCCCGGCCGGGGCCGCCGGGACCCCGGCCGGAGCCACCACCGACTGA	MDTHVSDTTTPAGAGEGPAGPVTDPAGHAACVVTLGAGGPTGGHRGELGGKGTRLAELSAAGLPVPPAFCLTTALFDAYLRETGIAAEAAGADPRTLRERILGTRMPASIADAVLDAYGSMGRPRVAVRSSGLREDSAAQSFAGQHDTVLDVCGDEDVLDAVLRCWASLWSDRATVYRDTDAPDALAVVVQEMIHTDVSGVMFTVDPVNPRPHRLVVEACQGLGEGLVSGQVSSDFFVVDDEKLEVVEERVRYKVTKCAPLEPGRIGMTKVDAAARSVPCLTHDQLRELGALAVRIRDLYGSEQDIEWGVRDGVFHLFQTRPITTRPAAPAAPSGALSPYVAPQPEPVLNGTLWSRMDIGEIFVGLMTPLGLSFARYYQRNVHTDCAGALGVRDTGEADLHMGFYQGHVYLNISYSSYLLAQCLPTRDQRHFTSRFVSEEVDLADYENPFGTFPGGMEDLLSTVHWLQHTAREMTQMKSRSQQMVDARLYEFDRARGLDLTRMSRRELHGELHRDLAWFHDMHIGYMPYYINAFAFYGLLTELCARWLGSDGVGLQNRVKTDMSSLRTVESAKEVWSVAQAAKNDPAVLRIIKDEPLEDIARLLREDPAGQRFWDRHMEPFLRANGTRGHQEMEITHPRWIDDPSYIFQMIRRYVADGFSIDDILRRSSGWSDDSREVLGRLPMPKRQVLDTVISLYALCSELRETTRMSMITSIWLVRNVVYEVGRRLVADGVLHSPDEIAHLDFEDVRRYLAGDEDAVRVFDRARIDAARRLHEHNKRLPEPPLTFVGVHDITASVRPAADGARLEGLAASPGRIVGRARIVEDLVWQADEFEAGEILVTGYTDASWTPLFAIAGGVVTDIGSMLSHSSIVAREFHVPSVVNTKDATQRINTGDLIVVDGDAGTVEVVESADTDPQGPAGAAGTPAGATTD	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	105.54	gnl|BL_ORD_ID|2235|hsp_num:0	2528			48	2649	rifampin; rifaximin; rifabutin; rifapentine
BGC0001063.1|Undecylprodigiosin_22 # 29731 # 30918 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.685	BGC0001063.1|Undecylprodigiosin_22 	29731	30918	+	Loose	1000	27.7202	eptA	38.18	3003576	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGATCCCCAACCAGTGGTATCCCATCGTCGAGGCGCAGGAGGTGGGCAACGACAAACCGCTCGGTGTGCGCCGCATGGGCCAGGACCTCGTGCTCTGGCGCGACATCGACGGCAACCTCGTCTGCCAGGGCGCCCGCTGCCCGCACAAGGGCGCCAACCTCGGCGACGGCCGCATGAAGGGCAACACCATCGAATGCCCGTACCACGGCTTCCGCTACGGAGCCGACGGTGCCTGCCGGGTGATCCCGGCGATGGGCTCCGAGGCCCGCATCCCCGGCTCGCTGCGGGTACCCACCTACCCGGTCCGGGAGCAGTTCGGCCTGGTGTGGATGTGGTGGGGCGACGAGCGCCCGACGGCCGACCTGCCGCCGGTGGCGGCCCCGGCCGAGGTGACGGACAACCGGAAGCTGTACGCCACCAAGCGCTGGACCCGCCCGGTGCACTACACCCGTTACATCGAGAGCCTGCTCGAGTTCTACCACGTGACCTACGTGCACCGGGACCACTGGTTCAACTACATCGACTACCTGCTCCTGTACGGCACCCCGAGCAAGTTCGGCCTCGACGGCCGCGAGCGGTACCTGGCCGCCACCCGGATCACCAACCACCGGGTGGAGACGGAGGCGGAGGGGCAGACCATCCGCTACTCCTTCGACCACTGCCAGGAGGACGACCCCACCAACACCACCCACTACGTCATCACGTTCACCTTCCCGTGCATGGTGCACGTGCAGACCGAGCAGTTCGAGACCACCTCCTGGCTGGTGCCCATCGACGACCAGAACACCGAGCACATCCTGCGCTGGTACGAGTACGAACAGGTCAAGCCCGTCCTGAGGTTCGAACCGCTGCGCCGTCTGCTGCCCTGGGCGTCCCTCTACATGGAGAAGTGGGTGCAGGACCCCCAGGACGTCCGCATCATGGAACACCAGGAACCCAAGATCAGCGCCGGCGGCGTGAACAAGTTCATCCCCGTCGACGAGATGAACGCCAAGTACATCTCGATGCGCGCCAAGCTGATCGCGGACGCCTCGGCCGCGCCCTCGTCACCGGCGCGGGCGGCGGAGCCCGAGCCGGAAGCGGCGGGGCGGGGCGGATCAGCGGCCCGTGCCACGGGCAACGGCAGGGGAGCGGCCGGCGGACGACGCGGCACCAAGCCCAAGGAGGACGCCGCCGCGCGCCCGTAG	MIPNQWYPIVEAQEVGNDKPLGVRRMGQDLVLWRDIDGNLVCQGARCPHKGANLGDGRMKGNTIECPYHGFRYGADGACRVIPAMGSEARIPGSLRVPTYPVREQFGLVWMWWGDERPTADLPPVAAPAEVTDNRKLYATKRWTRPVHYTRYIESLLEFYHVTYVHRDHWFNYIDYLLLYGTPSKFGLDGRERYLAATRITNHRVETEAEGQTIRYSFDHCQEDDPTNTTHYVITFTFPCMVHVQTEQFETTSWLVPIDDQNTEHILRWYEYEQVKPVLRFEPLRRLLPWASLYMEKWVQDPQDVRIMEHQEPKISAGGVNKFIPVDEMNAKYISMRAKLIADASAAPSSPARAAEPEPEAAGRGGSAARATGNGRGAAGGRRGTKPKEDAAARP	MLKRLLKRPSLNLLAWLLLAAFYISICLNIAFFKQVLQALPLDSLHNVLVFLSMPVVAFSVINIVLTLSSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMIANIIDTTPAESYALMTPQMLLTLGFSGVLAALIACWIKIKPATSRLRSVLFRGANILVSVLLILLVAALFYKDYASLFRNNKELVKSLSPSNSIVASWSWYSHQRLANLPLVRIGEDAHRNPLMQNEKRKNLTILIVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKEELAQHQEGVLDIIQRAGINVLWNDNDGGCKGACDRVPHQNVTALNLPDQCINGECYDEVLFHGLEEYINNLQGDGVIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTKEQLVNTYDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQKQVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQTCRRVSE	72.21	gnl|BL_ORD_ID|595|hsp_num:0	516			936	1092	polymyxin B
BGC0001063.1|Undecylprodigiosin_23 # 30961 # 31641 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.648	BGC0001063.1|Undecylprodigiosin_23 	30961	31641	+	Loose	200	27.335	vanT gene in vanN cluster	36.54	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTACGGCGGATACGACGCGTCGACCGGCCCCAAGGCCCTGGTGACGGCCTTCAACACCGTCGCCGTGGCCGGCGCCGTGTGGTTCCTGTTCGGCGGCGCGGACACCGTGGCCGACTGGTTCGGCACCGACTTCGACGAGGCGGTGACCCTGCGCCGGGTCCTGCTGGCGACCCTGTCGGTGCTCTACCTGCTGCGCTTCATCGCCACGAACTTCGTGATGCTCCAGCGCAAGATGGAGTGGTCGGAGTCGGCCACCATCGGGATCTGGGTCCTGGTGATCCACGGCACGATGGCGTACTTCGGCGGCACCAACGACGCCGGCGTGAGCGCGTTCACCTGGCTGGGCGTCGTGCTGTACCTCCTCGGGTCCTACCTGAACACGGGGTCGGAGTACCAGCGCAAACTCTGGAAGAAGCGCCCGGAGAACAAGGGCAAGCTCTACACCGAAGGCCTGTTCAAGCACTCGATGCACATCAACTACTTCGGTGACGCCGTGCTCTTCTCCGGGTTCGCGCTGGTCACGGGCACCCCGTGGGCCTTCGCCATCCCCCTGATCATGGTCTGCATGTTCGTCTTCCTGAACATCCCCATGCTCGACAAGTACCTCGCCGAGCGATACGGCGAGGCCTTCGACGAGTACGCGTCCCGGACGGCGAAGTTCGTCCCCTACGTGTACTGA	MYGGYDASTGPKALVTAFNTVAVAGAVWFLFGGADTVADWFGTDFDEAVTLRRVLLATLSVLYLLRFIATNFVMLQRKMEWSESATIGIWVLVIHGTMAYFGGTNDAGVSAFTWLGVVLYLLGSYLNTGSEYQRKLWKKRPENKGKLYTEGLFKHSMHINYFGDAVLFSGFALVTGTPWAFAIPLIMVCMFVFLNIPMLDKYLAERYGEAFDEYASRTAKFVPYVY	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	32.29	gnl|BL_ORD_ID|4745|hsp_num:0	1983			432	585	vancomycin
